Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Updated FDA Calendar Of 73 Decision Dates
Nov 22, 2008 12:57 PM
- Stock Opportunities in a 'Roadhouse Blues' Market
Nov 21, 2008 11:39 AM
- Who Will Replace GM In The Dow?
Nov 11, 2008 10:24 AM
- Rigel Pharmaceuticals– Crisis Or Opportunity?
Nov 10, 2008 09:57 AM
- A Backlog Of Decisions Is Building At The FDA
Nov 07, 2008 11:48 AM
- Healthspring, Inc. - Value - Zacks Rank Buy
Nov 03, 2008 01:05 PM
- Virtual Funds: Healthcare Fund's Ranking/Performance In Q3 '08 And Overall
Nov 01, 2008 01:31 PM
- Halloween Comes Early - Earnings Trends
Oct 30, 2008 09:46 PM
- Amgen, Inc. - Value - Zacks Rank Buy
Oct 29, 2008 11:40 AM
- Cup & Handle - Agnico-Eagle Mines Limited (USA) (Public, NYSE:AEM)
Oct 24, 2008 08:59 PM
- Earnings, Revenue Off at Memory Pharmaceuticals
Nov 14, 2008 05:17 PM
- Health Care Poised to Weather Recession
Nov 02, 2008 10:54 AM
- Election to benefit some industries, harm others
Nov 02, 2008 09:57 AM
- Hard Times Make Retirement Decisions Tougher
Nov 01, 2008 05:56 PM
- Health care, defense poised to weather recession
Nov 01, 2008 01:54 PM
- Letter: Cheaper Alternative
Oct 27, 2008 04:56 PM
- Lehman-Linked Biotech Firm Plans IPO
Sep 18, 2008 06:55 AM
- Little Hiring in the County Expected in Last Quarter of Year
Sep 09, 2008 03:57 PM
- County's Jobless Rate Nears 7 Percent
Aug 16, 2008 06:53 AM
- Biographical information on Frank Biondi Jr.
Aug 14, 2008 05:56 PM
- Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union
Nov 21, 2008 08:56 AM
- MattsonJack Study Reveals Cachexia Emerging As a Lucrative Opportunity for Pharma Companies
Nov 20, 2008 11:03 AM
- Seven Summits Research Releases Alerts on WMT, AMGN, DIS, ICE, and URBN
Nov 20, 2008 09:31 AM
- Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
Nov 19, 2008 06:57 PM
- Amgen Positioned to Deliver Attractive Growth Over Next Five Years
Nov 07, 2008 01:39 PM
- Amgen to Webcast 2008 Business Review Meeting on November 7 From Millennium Hotel in New York
Nov 03, 2008 04:32 PM
- Call for Applications: The Amgen Award for Science Teaching Excellence
Nov 03, 2008 01:18 PM
- Brainware Joins Fujitsu ISV Program to Market End-to-End Document Processing Solution
Nov 03, 2008 10:01 AM
- BrainScope Company, Inc. Announces New Investment and Leadership to Fuel Growth
Oct 29, 2008 10:00 AM
- Seven Summits Research Releases Alerts on HD, AMGN, NUE, FDX, and LH
Oct 28, 2008 09:31 AM
- Form 4 CHOATE JERRY D For: Nov 13 (10K)
Nov 14, 2008 07:58 PM
- Form 4 AMGEN INC For: Nov 10 Filed by: SHARER KEVIN W (10K)
Nov 10, 2008 07:12 PM
- Form 4 AMGEN INC For: Nov 04 Filed by: Flanagan Thomas James (10K)
Nov 06, 2008 06:04 PM
- Form 4 AMGEN INC For: Nov 04 Filed by: COFFMAN VANCE D (10K)
Nov 05, 2008 01:08 PM
- Form 4 AMGEN INC For: Oct 29 Filed by: Michael A Kelly (10K)
Oct 30, 2008 04:35 PM
- Form 4 AMGEN INC For: Oct 29 Filed by: PELHAM JUDITH C (10K)
Oct 29, 2008 07:32 PM
- Form 4/A de Carbonnel Francois For: Oct 27 (10K)
Oct 29, 2008 01:47 PM
- Form 4 AMGEN INC For: Oct 24 Filed by: MORROW GEORGE J (10K)
Oct 28, 2008 02:56 PM
- Form 4 AMGEN INC For: Oct 24 Filed by: Flanagan Thomas James (10K)
Oct 28, 2008 02:56 PM
- Form 4 AMGEN INC For: Oct 23 Filed by: BONANNI FABRIZIO (10K)
Oct 27, 2008 09:01 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
AMGN
|
Compare to S&P
|
| YTD |
19.59 %
|
95.94 %
|
| 4 Weeks |
-7.26 %
|
0.24 %
|
| 12 Weeks |
-8.06 %
|
27.44 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 7.08 %
|
|
EPS Growth in Last Year: 14.15 %
|
|
Sales Growth in Last Quarter: 2.95 %
|
|
Sales Growth in Last Quarter: 7.31 %
|
|
|
